PPA
EVH icon

Parametric Portfolio Associates’s Evolent Health EVH Stock Holding History

Parametric Portfolio Associates’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$2.34M Sell
72,389
-34,399
-32% -$901K ﹤0.01% 2337
2021
Q4 		$2.96M Buy
106,788
+10,637
+11% +$305K ﹤0.01% 2205
2021
Q3 		$2.98M Buy
96,151
+7,418
+8% +$178K ﹤0.01% 2170
2021
Q2 		$1.87M Buy
88,733
+2,998
+3% +$60K ﹤0.01% 2475
2021
Q1 		$1.73M Buy
85,735
+6,940
+9% +$132K ﹤0.01% 2877
2020
Q4 		$1.26M Sell
78,795
-46,238
-37% -$611K ﹤0.01% 2926
2020
Q3 		$1.55M Buy
125,033
+114,500
+1,087% +$1.35M ﹤0.01% 2658
2020
Q2 		$75K Sell
10,533
-20,588
-66% -$138K ﹤0.01% 3824
2020
Q1 		$169K Sell
31,121
-52,626
-63% -$470K ﹤0.01% 3595
2019
Q4 		$758K Buy
83,747
+6,295
+8% +$51.1K ﹤0.01% 3200
2019
Q3 		$557K Buy
77,452
+36,134
+87% +$259K ﹤0.01% 3302
2019
Q2 		$328K Sell
41,318
-26,201
-39% -$310K ﹤0.01% 3538
2019
Q1 		$849K Sell
67,519
-24,557
-27% -$389K ﹤0.01% 3102
2018
Q4 		$1.84M Sell
92,076
-61,418
-40% -$1.42M ﹤0.01% 2636
2018
Q3 		$4.36M Buy
153,494
+92,836
+153% +$2.21M ﹤0.01% 2137
2018
Q2 		$1.28M Sell
60,658
-3,919
-6% -$74.2K ﹤0.01% 2930
2018
Q1 		$920K Buy
64,577
+6,557
+11% +$93.9K ﹤0.01% 3067
2017
Q4 		$714K Buy
58,020
+2,871
+5% +$40.5K ﹤0.01% 3162
2017
Q3 		$982K Sell
55,149
-7,146
-11% -$147K ﹤0.01% 3059
2017
Q2 		$1.58M Buy
62,295
+52,746
+552% +$1.27M ﹤0.01% 2699
2017
Q1 		$213K Buy
+9,549
New +$183K ﹤0.01% 3576
2016
Q4 		– Sell
-10,380
Closed -$256K – 3783
2016
Q3 		$256K Buy
+10,380
New +$243K ﹤0.01% 3489

Other funds holding EVH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $327M AUM 22.96% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.81B AUM 83.9% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return

Parametric Portfolio Associates's EVH Position: Q1 2022 in Review

Parametric Portfolio Associates reduced its Evolent Health (EVH) stake by 32% in Q1 2022, selling an estimated $901K and leaving 72,389 shares worth $2.34M. The position accounts for ﹤0.01% of the portfolio, ranked #2337.

Parametric Portfolio Associates first reported a position in EVH in Q3 2016 and has held it in 22 quarters since. The position peaked at $4.36M in Q3 2018. 218 funds tracked by Wall St. Rank hold EVH as of Q1 2022.

  • Parametric Portfolio Associates held 72,389 shares of Evolent Health worth $2.34M as of Q1 2022.
  • Parametric Portfolio Associates sold 34,399 Evolent Health shares in Q1 2022, an estimated $901K.
  • Evolent Health made up ﹤0.01% of Parametric Portfolio Associates's portfolio in Q1 2022, its #2337 holding.
  • Parametric Portfolio Associates first reported a position in Evolent Health in Q3 2016 and has held it in 22 quarters since.
  • Parametric Portfolio Associates's Evolent Health position peaked at $4.36M in Q3 2018.
  • 218 funds tracked by Wall St. Rank held Evolent Health as of Q1 2022.

Based on Parametric Portfolio Associates's 13F filing for Q1 2022, filed 16 May 2022.